CVS Health (NYSE:CVS) Price Target Raised to $92.00 at Robert W. Baird

CVS Health (NYSE:CVS) had its price target increased by Robert W. Baird from $82.00 to $92.00 in a research note issued to investors on Wednesday, Marketbeat Ratings reports. They currently have an outperform rating on the pharmacy operator’s stock.

A number of other equities analysts have also issued reports on the company. Cantor Fitzgerald increased their price objective on CVS Health from $78.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, October 30th. Morgan Stanley upped their price objective on shares of CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a report on Wednesday. Truist Financial restated a “buy” rating and set a $95.00 price target (up from $92.00) on shares of CVS Health in a research report on Thursday, October 30th. Argus boosted their price target on shares of CVS Health from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, November 4th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $101.00 price objective (up previously from $99.00) on shares of CVS Health in a research note on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $93.24.

CVS Health Trading Up 1.1%

NYSE:CVS opened at $79.08 on Wednesday. CVS Health has a 12-month low of $43.56 and a 12-month high of $85.15. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The business has a 50 day simple moving average of $78.87 and a 200 day simple moving average of $71.64. The firm has a market capitalization of $100.39 billion, a P/E ratio of 208.12, a P/E/G ratio of 0.76 and a beta of 0.48.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts predict that CVS Health will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio is presently 700.00%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Cantor Fitzgerald Investment Advisors L.P. grew its holdings in CVS Health by 1.6% in the 2nd quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after buying an additional 6,615 shares in the last quarter. Brandywine Global Investment Management LLC grew its stake in shares of CVS Health by 20.1% in the first quarter. Brandywine Global Investment Management LLC now owns 3,421,519 shares of the pharmacy operator’s stock valued at $231,808,000 after acquiring an additional 572,533 shares in the last quarter. Holderness Investments Co. bought a new position in CVS Health during the first quarter worth about $300,000. Red Mountain Financial LLC bought a new stake in CVS Health in the 2nd quarter valued at about $293,000. Finally, AE Wealth Management LLC grew its position in shares of CVS Health by 607.5% during the 2nd quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock worth $16,708,000 after purchasing an additional 207,984 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.